BackOncocyte Overview
Oncocyte Corporation

Oncocyte Discounted Cash Flow

DCF Analysis for OCX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-1.65

Current Fair Value

$-1.65
↓ 151.7% Downside

Overvalued by 151.7% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading